N/A
Completed N=46
Intelligent Pain Management System for Assessing Pain in Cancer Patients
Source: ClinicalTrials.gov NCT02765269 ↗Enrolled (actual)
46
Serious AEs
—
Results posted
Oct 2016
Primary outcomePrimary: Feasibility of Mobile Application Assessed by Observing the Number of Daily Pain Assessments Recorded Among Patients — 2.37 pain assessments per day
Summary
The purpose of this study is to determine whether the Intelligent Pain Management System (IPMS) could make recording and interfering pain timely among cancer patients with pain. The system's usability, feasibility, compliance, and satisfaction will also be assessed.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Mobile Application Assessed by Observing the Number of Daily Pain Assessments Recorded Among Patients |
2.37 | — |
| SECONDARY Pain Management |
2.20; 2.95 | — |
| SECONDARY Users' Satisfaction (Questionnaire) |
9; 16; 0 | — |
| SECONDARY Karnofsky Performance Score Evaluation |
68.80; 56.19 | — |
Eligibility Criteria
Inclusion Criteria
- the patient was able to read Chinese and use smart phones;
- the patient was diagnosed with cancer and has self-reported cancer pain within a month prior to the study;
- the patient was being seen on a regular basis by the oncology team;
- the patient was under standard analgesia treatments;
- the patient was estimated to have over 3 months survival time.
Exclusion Criteria
- the patients who self-reported to have severe cognitive impairments or major comorbid illnesses that would interfere with pain assessment.
Data sourced from ClinicalTrials.gov (NCT02765269). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.